Alectinib (INN), sold under the brand name Alecensa, is an anticancer medication that is used to treat non-small-cell lung cancer (NSCLC). It blocks the activity of anaplastic lymphoma kinase (ALK). It is taken by mouth. It was developed by Chugai Pharmaceutical Co. Japan, which is part of the Hoffmann-La Roche group.
The most common side effects include constipation, muscle pain and edema (swelling) including of the ankles and feet, the face, the eyelids and the area around the eyes.
Alectinib was approved for medical use in Japan in 2014, the United States in 2015, Canada in 2016, Australia in 2017, the European Union in 2017, and the United Kingdom in 2021. |
Read full article at Wikipedia
|
InChI=1S/C30H34N4O2.ClH/c1-4-20-16-23-24(17-26(20)34-9-7-21(8-10-34)33-11-13-36-14-12-33)30(2,3)29-27(28(23)35)22-6-5-19(18-31)15-25(22)32-29;/h5-6,15-17,21,32H,4,7-14H2,1-3H3;1H |
GYABBVHSRIHYJR-UHFFFAOYSA-N |
Cl.C1OCCN(C1)C2CCN(CC2)C3=CC4=C(C=C3CC)C(C5=C(C4(C)C)NC=6C5=CC=C(C6)C#N)=O |
|
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that interferes with the action of receptor protein-tyrosine kinase (EC 2.7.10.1).
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
9-ethyl-6,6-dimethyl-8-[4-(morpholin-4-yl)piperidin-1-yl]-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile hydrochloride
|
AF-802 hydrochloride
|
ChemIDplus
|
alectinib monohydrochloride
|
ChEBI
|
CH5424802
|
ChEBI
|
1256589-74-8
|
CAS Registry Number
|
ChemIDplus
|
23594297
|
Reaxys Registry Number
|
Reaxys
|
21575866
|
PubMed citation
|
SUBMITTER
|
24509625
|
PubMed citation
|
Europe PMC
|
24736079
|
PubMed citation
|
Europe PMC
|
24887559
|
PubMed citation
|
Europe PMC
|
25205428
|
PubMed citation
|
Europe PMC
|
25349307
|
PubMed citation
|
Europe PMC
|
25398579
|
PubMed citation
|
Europe PMC
|
25428710
|
PubMed citation
|
Europe PMC
|
25502629
|
PubMed citation
|
Europe PMC
|
25526238
|
PubMed citation
|
Europe PMC
|
25556163
|
PubMed citation
|
Europe PMC
|
25678258
|
PubMed citation
|
Europe PMC
|
26082648
|
PubMed citation
|
Europe PMC
|
26753004
|
PubMed citation
|
Europe PMC
|
PMC4699265
|
PubMed Central citation
|
Europe PMC
|
|